RxDoctor Payments DataLook up a doctor →

Sandra Oviedo, PA

Physician Assistant · Las Vegas, NVNPI 1053084905

Payments from drug & device makers

$20,616in general payments, 2019–2025

Across 935 payments — averaging $22.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$3K
  • AbbVie$3K
  • Lundbeck LLC$1K
  • Neurocrine Biosciences, Inc.$1K
  • UCB, Inc.$962
  • EMD Serono, Inc.$901
  • plus $11K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biogen116$2,839
AbbVie(2 entities)139$2,644
Lundbeck LLC68$1,311
Neurocrine Biosciences, Inc.50$1,151
UCB, Inc.29$962
EMD Serono, Inc.29$901
Teva Pharmaceuticals USA, Inc.50$819
Acadia Pharmaceuticals Inc36$813
Argenx US, Inc.25$746
Genentech USA, Inc.35$734
Eisai Inc.40$638
Novartis41$598
SK Life Science, Inc.15$506
Corium, LLC24$440
Sanofi13$416
Neurelis, Inc.31$389
Johnson & Johnson(2 entities)14$374
AstraZeneca(2 entities)17$344
Lilly USA, LLC16$343
Takeda Pharmaceuticals U.S.A., Inc.10$335
Pfizer16$319
Amgen(2 entities)17$299
TG Therapeutics, Inc.6$236
Bristol Myers Squibb11$202
Janssen Scientific Affairs, LLC2$192
Biohaven Pharmaceutical Holding Company Ltd.11$164
Amneal Pharmaceuticals LLC7$160
Sumitomo Pharma America, Inc.5$126
Revance Therapeutics, Inc.2$119
Alnylam Pharmaceuticals Inc.5$116
Genentech, Inc.1$110
ANI Pharmaceuticals, Inc.4$98
Ipsen Biopharmaceuticals, Inc3$93
Jazz Pharmaceuticals Inc.3$90
Banner Life Sciences, LLC4$85
Abbott2$70
MDD US Operations, LLC3$67
Otsuka America Pharmaceutical, Inc.3$66
Grifols USA, LLC3$65
Tersera Therapeutics LLC2$64
Springworks Therapeutics, Inc.2$52
Livanova USA, Inc.1$44
Biohaven Pharmaceuticals, Inc.3$41
Tanabe Pharma America, Inc.2$38
Catalyst Pharmaceuticals, Inc.1$38
Octapharma USA, Inc.2$33
Avadel CNS Pharmaceuticals, LLC1$29
Mallinckrodt Hospital Products Inc.1$25
Acorda Therapeutics, Inc1$25
Scilex Pharmaceuticals Inc.1$24
NS Pharma, Inc.1$23
Sunovion Pharmaceuticals Inc.1$22
C2n Diagnostics, LLC1$22
Insightec,inc1$21
Electromed, Inc.1$21
Merz Pharmaceuticals, LLC1$19
Sandoz1$17
Vanda Pharmaceuticals Inc.1$17
Cala Health, Inc.1$17
Upsher-smith Laboratories LLC1$16

How this compares

$20,616 in reported general payments places this provider in the 95th percentile of 881 physician assistant providers in Nevada.

See all physician assistant providers in Nevada →

Medicare billing

Part B allowed, 2024
$50,309
Medicare patients
338
Services billed
659

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physician assistant in Las Vegas

See the full list for Nevada →

Where these figures come from

Is this you, or does something look wrong? →